A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects With Advanced Non-Small Cell Lung Cancer
What is the purpose of this trial?
The purpose of this study is to determine if ;MEDI4736 ;will be adequately tolerated in combination with tremelimumab in subjects with advanced NSCLC.
- MedImmune, Inc
- Last Updated:
- Study HIC#: